Cite Filings / STLN / 0001628280-23-008315

Feed Companies Filings Check

Sign in

10-K

Annual Report

Starling Oncology, Inc. Filed 2023-03-16 Acc 0001628280-23-008315

Documents 1

10-K Annual Report , toi-20221231.htm

Around this filing

2024-03-28 10-K Annual Report
2023-03-21 4 Director bought 50,000 shares at an average $0.55 ($27,495)
2023-03-21 4 Director acquired 19,685 shares (grant or award)
2023-03-21 4 Chief Executive Officer acquired 168,512 shares (grant or award)
2023-03-17 8-K/A Results of operations
2023-03-16 10-K Annual Report
2022-03-11 10-K Annual Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading toi-20221231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…